Filing Details
- Accession Number:
- 0001104659-11-012545
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-04 20:46:27
- Reporting Period:
- 2011-03-02
- Filing Date:
- 2011-03-04
- Accepted Time:
- 2011-03-04 20:46:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1201580 | D Samuel Colella | C/O Versant Ventures 3000 Sand Hill Road, #4-210 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-03-02 | 505,571 | $0.00 | 1,082,174 | No | 4 | J | Indirect | Versant Venture Capital I, L.P. |
Common Stock | Disposition | 2011-03-02 | 10,109 | $0.00 | 20,838 | No | 4 | J | Indirect | Versant Side Fund I, L.P. |
Common Stock | Acquisiton | 2011-03-02 | 4,300 | $0.00 | 8,726 | No | 4 | J | Indirect | Colella Family Partners, L.P. |
Common Stock | Acquisiton | 2011-03-02 | 8,753 | $0.00 | 17,757 | No | 4 | J | Indirect | Colella Family Trust UTA Dtd. 9/21/92 |
Common Stock | Disposition | 2011-03-03 | 10,571 | $25.45 | 19,358 | No | 4 | S | Indirect | Versant Affiliates Fund I-A, L.P. |
Common Stock | Disposition | 2011-03-03 | 23,749 | $25.45 | 37,552 | No | 4 | S | Indirect | Versant Affiliates Fund I-B, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | J | Indirect | Versant Venture Capital I, L.P. |
No | 4 | J | Indirect | Versant Side Fund I, L.P. |
No | 4 | J | Indirect | Colella Family Partners, L.P. |
No | 4 | J | Indirect | Colella Family Trust UTA Dtd. 9/21/92 |
No | 4 | S | Indirect | Versant Affiliates Fund I-A, L.P. |
No | 4 | S | Indirect | Versant Affiliates Fund I-B, L.P. |
Footnotes
- The Reporting Person is a managing member of Versant Ventures I, LLC ("VVI-LLC"), which is the general partner of each of Versant Side Fund I, L.P., Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"). As such, the Reporting Person shares voting and investment power over the shares held by the Versant Funds and may be deemed to have indirect beneficial ownership of such shares. Versant Venture Capital I, L.P. made an in-kind distribution of 505,571 shares of common stock of the Issuer to their respective partners on March 2, 2011. Versant Side Fund I, L.P. made an in-kind distribution of 10,109 shares of common stock of the Issuer to their respective partners on March 2, 2011. The Reporting Person disclaims beneficial ownership of such shares held by the Versant Funds, except to the extent of his proportionate pecuniary interest therein, if any.
- The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions of 4,098 shares by Versant Venture Capital I, L.P. and 202 shares by Versant Side Fund I, L.P. on March 2, 2011. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.
- The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 ("Colella Trust"). The shares were received in in-kind distributions of 8,197 shares by Versant Venture Capital I, L.P. and 556 shares by Versant Side Fund I, L.P. on March 2, 2011. The Reporting Person is a trustee and beneficiary of the Colella Trust.
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $25.45 to $26.08 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.